Clinical Trial Update: Irinotecan Combination Chemotherapy for Refractory or Relapsed Brain Tumor in Children and Adolescents [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating irinotecan-based chemotherapy in pediatric patients with refractory or relapsed brain tumors. The current status of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor

Drugs mentioned

• Irinotecan (Irinotecan)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Brain Tumor | Phase 2 | Status: UNKNOWN